Skip to main navigation Skip to search Skip to main content

PIONEER: A multicenter, randomized, double-blind, double dummy, parallel group, active-controlled 8-week study to evaluate the effect of sacubitril and valsartan (LCZ696) versus enalapril on changes in NT-proBNP and safety and tolerability

Project: Research

Project Details

StatusFinished
Effective start/end date01/28/17 → 06/30/20

Funding

  • Novartis Pharmaceuticals Corporation: $147,468.00